Xiaohui Xu1, Hui Hu2, Gregory D Kearney3, Haidong Kan4, Genny Carrillo5, Xinguang Chen2. 1. a Department of Epidemiology and Biostatistics , School of Public Health, Texas A&M University , College Station , TX , USA. 2. b Department of Epidemiology , College of Public Health and Health Professions and College of Medicine, University of Florida , Gainesville , FL , USA. 3. c Department of Public Health , East Carolina University, Brody School of Medicine , Greenville , NC, USA. 4. d School of Public Health, Key Laboratory of Public Health Safety of the Ministry of Education and Key Laboratory of Health Technology Assessment of the Ministry of Health, Fudan University , Shanghai , China , and. 5. e Department of Environmental and Occupational Health , School of Public Health, Texas A&M Health Science Center , McAllen , TX , USA.
Abstract
BACKGROUND: Fractional concentration of exhaled nitric oxide (FeNO) is recommended by the American Thoracic Society (ATS) as a noninvasive biomarker of airway inflammation. In addition to inflammation, many factors may be associated with FeNO, particularly tobacco exposure; however, only age has been included as an influential factor for children below 12 years. Numerous studies have demonstrated negative associations between tobacco exposure and FeNO levels with self-reported data, but few with an objective assessment of smoking. METHODS: Data from the National Health and Nutrition Examination Survey (NHANES) 2007-2012 were analyzed to examine the association between FeNO and active/passive tobacco. Exposure was assessed by both self-report and serum cotinine levels among 11,160 subjects aged 6-79 years old with asthma, or without any respiratory disease. RESULTS: Study results indicated 28.8% lower FeNO, 95% CI [25.2%, 32.3%] and 38.1% lower FeNO, 95% CI: [28.1, 46.2] was observed among healthy and asthmatic participants with serum cotinine in the highest quartile compared to those in the lowest quartile, respectively. Self-reported smoking status and recent tobacco use were also associated with decreased FeNO. Self-reported passive smoking was significantly associated with a 1.0% decrease in FeNO 95% CI [0.0, 2.0] among asthmatic subjects but not among healthy subjects. CONCLUSIONS: Active smoking, whether measured by self-report or serum cotinine, was associated with decreased FeNO levels. In addition to age, increased attention should be given to tobacco exposure when using FeNO as a biomarker in clinical practice. Additional research is needed to establish reference value of FeNO considering the impact of tobacco exposure.
BACKGROUND: Fractional concentration of exhaled nitric oxide (FeNO) is recommended by the American Thoracic Society (ATS) as a noninvasive biomarker of airway inflammation. In addition to inflammation, many factors may be associated with FeNO, particularly tobacco exposure; however, only age has been included as an influential factor for children below 12 years. Numerous studies have demonstrated negative associations between tobacco exposure and FeNO levels with self-reported data, but few with an objective assessment of smoking. METHODS: Data from the National Health and Nutrition Examination Survey (NHANES) 2007-2012 were analyzed to examine the association between FeNO and active/passive tobacco. Exposure was assessed by both self-report and serum cotinine levels among 11,160 subjects aged 6-79 years old with asthma, or without any respiratory disease. RESULTS: Study results indicated 28.8% lower FeNO, 95% CI [25.2%, 32.3%] and 38.1% lower FeNO, 95% CI: [28.1, 46.2] was observed among healthy and asthmatic participants with serum cotinine in the highest quartile compared to those in the lowest quartile, respectively. Self-reported smoking status and recent tobacco use were also associated with decreased FeNO. Self-reported passive smoking was significantly associated with a 1.0% decrease in FeNO 95% CI [0.0, 2.0] among asthmatic subjects but not among healthy subjects. CONCLUSIONS: Active smoking, whether measured by self-report or serum cotinine, was associated with decreased FeNO levels. In addition to age, increased attention should be given to tobacco exposure when using FeNO as a biomarker in clinical practice. Additional research is needed to establish reference value of FeNO considering the impact of tobacco exposure.
Authors: Coralie Barrera; Pascal Wild; Victor Dorribo; Dessislava Savova-Bianchi; Audrey Laboissière; Jacques A Pralong; Brigitta Danuser; Peggy Krief; Laurence Millon; Gabriel Reboux; Hélène Niculita-Hirzel Journal: Int Arch Occup Environ Health Date: 2018-05-26 Impact factor: 3.015
Authors: YiChieh Kuo; Francis Fu-Sheng Wu; YingChung Lee; Theodore Rong-Yei Lin; Julian Crane; Robert Siebers Journal: Int J Occup Environ Med Date: 2018-10
Authors: Peter G Shields; Micah Berman; Theodore M Brasky; Jo L Freudenheim; Ewy Mathe; Joseph P McElroy; Min-Ae Song; Mark D Wewers Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-06-22 Impact factor: 4.254
Authors: Anthony C Oliver; Michael DeSarno; Charles G Irvin; David Kaminsky; Jennifer W Tidey; Stacey C Sigmon; Sarah H Heil; Diann E Gaalema; Dustin Lee; Janice Y Bunn; Danielle R Davis; Joanna M Streck; Thomas Gallagher; Stephen T Higgins Journal: Nicotine Tob Res Date: 2022-01-01 Impact factor: 5.825
Authors: Pierachille Santus; Maurizio Rizzi; Dejan Radovanovic; Andrea Airoldi; Andrea Cristiano; Rosalynn Conic; Stephen Petrou; Paolo Daniele Maria Pigatto; Nicola Bragazzi; Delia Colombo; Mohamad Goldust; Giovanni Damiani Journal: Biomed Res Int Date: 2018-09-23 Impact factor: 3.411
Authors: Giulia Squillacioti; Valeria Bellisario; Amelia Grosso; Federica Ghelli; Pavilio Piccioni; Elena Grignani; Angelo Corsico; Roberto Bono Journal: Int J Environ Res Public Health Date: 2020-03-04 Impact factor: 3.390